awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35231826-93042EC6-AE4D-48EA-AA7B-B6E4C2F60197
Q35231826-93042EC6-AE4D-48EA-AA7B-B6E4C2F60197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-93042EC6-AE4D-48EA-AA7B-B6E4C2F60197
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
P2860
Q35231826-93042EC6-AE4D-48EA-AA7B-B6E4C2F60197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-93042EC6-AE4D-48EA-AA7B-B6E4C2F60197
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966528fce6da87a67c64b3b0add2cb5df3955829
P2860
Silibinin: a thorny therapeutic for EGF-R expressing tumors?